Jonathan Lovell, UB professor of biotechnologies and co-founder of UB spinoff POP Biotechnologies, advances a vaccine platform, proven effective for COVID-19, that could be key in responding to evolving bird flu strains.
When businesses and universities collide, life-changing innovations are born. From developing novel materials to pioneering COVID-19 vaccine candidates, impacts made by UB startups, researchers and industry partners are as diverse as they are far-reaching.
Life Sciences, Advanced Manufacturing, Tech Transfer
Tracy Krawczyk-Schiedel
Assistant VP for Communications, Marketing & Digital Operations tracykra@buffalo.edu
Startups, Incubators
Jessica Szklany
Associate Director of Marketing Communications
jszklany@buffalo.edu